XML 10 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses:    
Research and development $ 26,552 $ 12,939
General and administrative 4,636 3,795
Total operating expenses 31,188 16,734
Loss from operations (31,188) (16,734)
Other income, net 1,907 2,080
Net loss $ (29,281) $ (14,654)
Net loss per share, basic $ (0.46) $ (0.27)
Net loss per share, diluted $ (0.46) $ (0.27)
Weighted average common shares outstanding, basic 63,964,008 53,553,707
Weighted average common shares outstanding, diluted 63,964,008 53,553,707
Comprehensive loss:    
Net loss $ (29,281) $ (14,654)
Other comprehensive loss:    
Unrealized loss on marketable securities (94) (106)
Total other comprehensive loss (94) (106)
Total comprehensive loss $ (29,375) $ (14,760)